Baker / Tisch Capital (GP), LLC Insider Trading Transactions
Get free email notifications about insider trading for Baker / Tisch Capital (GP), LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Baker / Tisch Capital (GP), LLC. Baker / Tisch Capital (GP), LLC is 10% Owner in BIOCRYST PHARMACEUTICALS INC ($BCRX) and Director in INCYTE CORP ($INCY) and Director in NEUROGEN CORP ($NRGN) and 10% Owner in VIROPHARMA INC ($VPHM) and Director in SYNAGEVA BIOPHARMA CORP ($GEVA) and 10% Owner in ADOLOR CORP ($ADLR) and 10% Owner in ALLOS THERAPEUTICS INC ($ALTH) and 10% Owner in Ardea Biosciences, Inc./DE ($IBPI) and Director in SEATTLE GENETICS INC /WA ($SGEN) and Director in GENOMIC HEALTH INC ($GHDX).
Latest Insider Trading Transactions of Baker / Tisch Capital (GP), LLC
Sentiment: All, ADLR, ALTH, IBPI, BCRX, GHDX, INCY, NRGN, SGEN, GEVA, VPHM
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Nov 13 2007 | INCY | INCYTE CORP | Baker / Tisch Capital (GP), LL ... | Director | Buy | P | 8.20 | 608 | 4,986 | 87,878 | 87.3 K to 87.9 K (+0.70 %) |
Nov 13 2007 | INCY | INCYTE CORP | Baker / Tisch Capital (GP), LL ... | Director | Buy | P | 8.30 | 496 | 4,117 | 87,270 | 86.8 K to 87.3 K (+0.57 %) |
Nov 13 2007 | INCY | INCYTE CORP | Baker / Tisch Capital (GP), LL ... | Director | Buy | P | 7.70 | 700 | 5,392 | 86,774 | 86.1 K to 86.8 K (+0.81 %) |
Nov 13 2007 | INCY | INCYTE CORP | Baker / Tisch Capital (GP), LL ... | Director | Buy | P | 7.90 | 13 | 103 | 86,074 | 86.1 K to 86.1 K (+0.02 %) |
Dec 21 2007 | IBPI | Ardea Biosciences, ... | Baker / Tisch Capital (GP), LL ... | 10% Owner | Buy | P | 13.25 | 15,754 | 208,741 | 53,329 | 37.6 K to 53.3 K (+41.93 %) |
Jul 11 2007 | SGEN | SEATTLE GENETICS I ... | Baker / Tisch Capital (GP), LL ... | Director | Option Exercise | C | 0.00 | 31,650 | 0 | 0 | |
Jul 11 2007 | SGEN | SEATTLE GENETICS I ... | Baker / Tisch Capital (GP), LL ... | Director | Buy | C | 0.00 | 316,500 | 0 | 320,498 | 4 K to 320.5 K (+7,916.46 %) |
Apr 17 2007 | VPHM | VIROPHARMA INC | Baker / Tisch Capital (GP), LL ... | 10% Owner | Sell | S | 15.44 | 646 | 9,973 | 68,187 | 68.8 K to 68.2 K (-0.94 %) |
Apr 17 2007 | VPHM | VIROPHARMA INC | Baker / Tisch Capital (GP), LL ... | 10% Owner | Sell | S | 15.45 | 22 | 340 | 68,833 | 68.9 K to 68.8 K (-0.03 %) |
Apr 17 2007 | VPHM | VIROPHARMA INC | Baker / Tisch Capital (GP), LL ... | 10% Owner | Sell | S | 15.43 | 107 | 1,651 | 68,855 | 69 K to 68.9 K (-0.16 %) |
Apr 17 2007 | VPHM | VIROPHARMA INC | Baker / Tisch Capital (GP), LL ... | 10% Owner | Sell | S | 15.54 | 119 | 1,849 | 68,962 | 69.1 K to 69 K (-0.17 %) |
Apr 17 2007 | VPHM | VIROPHARMA INC | Baker / Tisch Capital (GP), LL ... | 10% Owner | Sell | S | 15.44 | 252 | 3,891 | 69,081 | 69.3 K to 69.1 K (-0.36 %) |
Apr 17 2007 | VPHM | VIROPHARMA INC | Baker / Tisch Capital (GP), LL ... | 10% Owner | Sell | S | 15.30 | 1,480 | 22,647 | 69,333 | 70.8 K to 69.3 K (-2.09 %) |
Apr 17 2007 | VPHM | VIROPHARMA INC | Baker / Tisch Capital (GP), LL ... | 10% Owner | Sell | S | 15.32 | 669 | 10,251 | 70,813 | 71.5 K to 70.8 K (-0.94 %) |
Jun 13 2007 | IBPI | Ardea Biosciences, ... | Baker / Tisch Capital (GP), LL ... | 10% Owner | Option Exercise | X | 1.03 | 21,044 | 21,738 | 0 | |
Jun 13 2007 | IBPI | Ardea Biosciences, ... | Baker / Tisch Capital (GP), LL ... | 10% Owner | Buy | X | 1.03 | 21,044 | 21,738 | 37,115 | 16.1 K to 37.1 K (+130.94 %) |
Jun 21 2007 | ALTH | ALLOS THERAPEUTICS ... | Baker / Tisch Capital (GP), LL ... | 10% Owner | Sell | S | 5.55 | 897 | 4,980 | 87,374 | 88.3 K to 87.4 K (-1.02 %) |
Jun 21 2007 | ALTH | ALLOS THERAPEUTICS ... | Baker / Tisch Capital (GP), LL ... | 10% Owner | Sell | S | 5.85 | 1,784 | 10,432 | 88,271 | 90.1 K to 88.3 K (-1.98 %) |
Jun 21 2007 | ALTH | ALLOS THERAPEUTICS ... | Baker / Tisch Capital (GP), LL ... | 10% Owner | Sell | S | 5.64 | 7,564 | 42,647 | 90,055 | 97.6 K to 90.1 K (-7.75 %) |
Jun 21 2007 | ALTH | ALLOS THERAPEUTICS ... | Baker / Tisch Capital (GP), LL ... | 10% Owner | Sell | S | 5.76 | 1,630 | 9,383 | 97,619 | 99.2 K to 97.6 K (-1.64 %) |
Feb 16 2007 | SGEN | SEATTLE GENETICS I ... | Baker / Tisch Capital (GP), LL ... | Director | Option Exercise | C | 0.00 | 8,000 | 0 | 31,650 | |
Feb 16 2007 | SGEN | SEATTLE GENETICS I ... | Baker / Tisch Capital (GP), LL ... | Director | Sell | S | 8.76 | 102,935 | 901,711 | 3,998 | 106.9 K to 4 K (-96.26 %) |
Feb 16 2007 | SGEN | SEATTLE GENETICS I ... | Baker / Tisch Capital (GP), LL ... | Director | Buy | C | 0.00 | 80,000 | 0 | 106,933 | 26.9 K to 106.9 K (+297.03 %) |
Mar 13 2007 | GHDX | GENOMIC HEALTH INC | Baker / Tisch Capital (GP), LL ... | Director | Buy | P | 18.28 | 3,181 | 58,152 | 193,759 | 190.6 K to 193.8 K (+1.67 %) |
Mar 05 2007 | GHDX | GENOMIC HEALTH INC | Baker / Tisch Capital (GP), LL ... | Director | Buy | P | 18.02 | 144 | 2,595 | 190,578 | 190.4 K to 190.6 K (+0.08 %) |
Mar 05 2007 | GHDX | GENOMIC HEALTH INC | Baker / Tisch Capital (GP), LL ... | Director | Buy | P | 17.77 | 199 | 3,536 | 190,434 | 190.2 K to 190.4 K (+0.10 %) |
Mar 05 2007 | GHDX | GENOMIC HEALTH INC | Baker / Tisch Capital (GP), LL ... | Director | Buy | P | 17.90 | 4 | 72 | 190,235 | 190.2 K to 190.2 K (0.00 %) |
Mar 05 2007 | GHDX | GENOMIC HEALTH INC | Baker / Tisch Capital (GP), LL ... | Director | Buy | P | 18.20 | 725 | 13,198 | 190,231 | 189.5 K to 190.2 K (+0.38 %) |
Feb 21 2007 | GHDX | GENOMIC HEALTH INC | Baker / Tisch Capital (GP), LL ... | Director | Buy | P | 18.54 | 513 | 9,513 | 189,506 | 189 K to 189.5 K (+0.27 %) |
Feb 21 2007 | GHDX | GENOMIC HEALTH INC | Baker / Tisch Capital (GP), LL ... | Director | Buy | P | 18.43 | 12 | 221 | 188,993 | 189 K to 189 K (+0.01 %) |
Feb 14 2007 | GHDX | GENOMIC HEALTH INC | Baker / Tisch Capital (GP), LL ... | Director | Buy | P | 18.36 | 1,449 | 26,604 | 188,981 | 187.5 K to 189 K (+0.77 %) |
Feb 14 2007 | GHDX | GENOMIC HEALTH INC | Baker / Tisch Capital (GP), LL ... | Director | Buy | P | 18.43 | 3 | 55 | 187,532 | 187.5 K to 187.5 K (0.00 %) |
Feb 14 2007 | GHDX | GENOMIC HEALTH INC | Baker / Tisch Capital (GP), LL ... | Director | Buy | P | 18.26 | 3,445 | 62,897 | 187,529 | 184.1 K to 187.5 K (+1.87 %) |
Feb 14 2007 | GHDX | GENOMIC HEALTH INC | Baker / Tisch Capital (GP), LL ... | Director | Buy | P | 17.89 | 449 | 8,034 | 184,084 | 183.6 K to 184.1 K (+0.24 %) |
Jan 26 2007 | IBPI | Ardea Biosciences, ... | Baker / Tisch Capital (GP), LL ... | 10% Owner | Buy | P | 6.00 | 666 | 3,996 | 15,372 | 14.7 K to 15.4 K (+4.53 %) |
Jan 26 2007 | IBPI | Ardea Biosciences, ... | Baker / Tisch Capital (GP), LL ... | 10% Owner | Buy | P | 5.98 | 223 | 1,335 | 14,706 | 14.5 K to 14.7 K (+1.54 %) |
Jan 11 2007 | IBPI | Ardea Biosciences, ... | Baker / Tisch Capital (GP), LL ... | 10% Owner | Buy | P | 5.28 | 1,067 | 5,630 | 14,483 | 13.4 K to 14.5 K (+7.95 %) |
Jan 11 2007 | IBPI | Ardea Biosciences, ... | Baker / Tisch Capital (GP), LL ... | 10% Owner | Buy | P | 4.83 | 333 | 1,608 | 13,416 | 13.1 K to 13.4 K (+2.55 %) |
Jan 11 2007 | IBPI | Ardea Biosciences, ... | Baker / Tisch Capital (GP), LL ... | 10% Owner | Buy | P | 4.77 | 467 | 2,227 | 13,083 | 12.6 K to 13.1 K (+3.70 %) |
Feb 01 2007 | ALTH | ALLOS THERAPEUTICS ... | Baker / Tisch Capital (GP), LL ... | 10% Owner | Buy | P | 6.00 | 43,954 | 263,724 | 99,249 | 55.3 K to 99.2 K (+79.49 %) |
Oct 04 2006 | GEVA | SYNAGEVA BIOPHARMA ... | Baker / Tisch Capital (GP), LL ... | Director | Sell | J | 0.00 | 126,415 | 0 | 160,420 | 286.8 K to 160.4 K (-44.07 %) |
Oct 04 2006 | NRGN | NEUROGEN CORP | Baker / Tisch Capital (GP), LL ... | Director | Sell | J | 0.00 | 160,934 | 0 | 210,556 | 371.5 K to 210.6 K (-43.32 %) |
Dec 27 2006 | IBPI | Ardea Biosciences, ... | Baker / Tisch Capital (GP), LL ... | 10% Owner | Buy | P | 4.00 | 1,558 | 6,232 | 12,616 | 11.1 K to 12.6 K (+14.09 %) |
Dec 27 2006 | IBPI | Ardea Biosciences, ... | Baker / Tisch Capital (GP), LL ... | 10% Owner | Buy | P | 3.85 | 2,904 | 11,184 | 11,058 | 8.2 K to 11.1 K (+35.61 %) |
Dec 08 2006 | GHDX | GENOMIC HEALTH INC | Baker / Tisch Capital (GP), LL ... | Director | Buy | P | 21.58 | 642 | 13,856 | 183,635 | 183 K to 183.6 K (+0.35 %) |
Dec 05 2006 | GHDX | GENOMIC HEALTH INC | Baker / Tisch Capital (GP), LL ... | Director | Buy | P | 22.55 | 1,315 | 29,648 | 182,993 | 181.7 K to 183 K (+0.72 %) |
Dec 05 2006 | GHDX | GENOMIC HEALTH INC | Baker / Tisch Capital (GP), LL ... | Director | Buy | P | 20.78 | 454 | 9,434 | 181,678 | 181.2 K to 181.7 K (+0.25 %) |
Dec 05 2006 | GHDX | GENOMIC HEALTH INC | Baker / Tisch Capital (GP), LL ... | Director | Buy | P | 20.38 | 175 | 3,567 | 181,224 | 181 K to 181.2 K (+0.10 %) |
Dec 05 2006 | GHDX | GENOMIC HEALTH INC | Baker / Tisch Capital (GP), LL ... | Director | Buy | P | 19.00 | 866 | 16,454 | 181,049 | 180.2 K to 181 K (+0.48 %) |
Dec 05 2006 | GHDX | GENOMIC HEALTH INC | Baker / Tisch Capital (GP), LL ... | Director | Buy | P | 20.79 | 306 | 6,361 | 180,183 | 179.9 K to 180.2 K (+0.17 %) |
Dec 05 2006 | GHDX | GENOMIC HEALTH INC | Baker / Tisch Capital (GP), LL ... | Director | Buy | P | 18.95 | 63 | 1,194 | 179,877 | 179.8 K to 179.9 K (+0.04 %) |
Dec 05 2006 | GHDX | GENOMIC HEALTH INC | Baker / Tisch Capital (GP), LL ... | Director | Buy | P | 18.99 | 57 | 1,082 | 179,814 | 179.8 K to 179.8 K (+0.03 %) |
Dec 05 2006 | GHDX | GENOMIC HEALTH INC | Baker / Tisch Capital (GP), LL ... | Director | Buy | P | 20.41 | 5,860 | 119,606 | 179,757 | 173.9 K to 179.8 K (+3.37 %) |